The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson’s disease

BACKGROUND/AIMS: Since the degeneration of the nigrostriatal dopaminergic pathway in Parkinson’s disease (PD) is associated with the inflammation process and decreased levels of cyclic nucleotides, inhibition of up-regulated cyclic nucleotide phosphodiesterases (PDEs) appears to be a promising thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwenkgrub, Joanna, Zaremba, Malgorzata, Joniec-Maciejak, Ilona, Cudna, Agnieszka, Mirowska-Guzel, Dagmara, Kurkowska-Jastrzębska, Iwona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533435/
https://www.ncbi.nlm.nih.gov/pubmed/28753652
http://dx.doi.org/10.1371/journal.pone.0182019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533435/
https://www.ncbi.nlm.nih.gov/pubmed/28753652
http://dx.doi.org/10.1371/journal.pone.0182019

Ejemplares similares